MacroGenics, Inc. Share Price
NASDAQ: MGNXHealthcare
Live MacroGenics, Inc. Share Price Chart
O H L
MacroGenics, Inc. Performance Overview
Days Range
▼
$4.10Low
$4.13High
Markets Today
| Previous Close | $4.13 |
|---|---|
| Open | $4.12 |
| Volume | 65,251 |
| Day's Range | $4.10 - $4.13 |
| 52W Range | $1.29 - $5.08 |
| Market Cap | $259.90 M |
Historical Performance
| 1M Returns | +0.98 |
|---|---|
| 3M Returns | 0.00 |
| 6M Returns | +38.59 |
| 1Y Returns | +138.73 |
| 5Y Returns | -79.83 |
| 10Y Returns | -86.61 |
MacroGenics, Inc. Fundamentals
| Market Cap | $259.90 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $149.50 M |
| ROE TTM | -0.87 |
| EPS TTM | $-1.63 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 6.06 |
| EBITDA | $-65.67 M |
| Profit Margin | -49.91 |
| Market Cap | $259.90 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $149.50 M |
| ROE TTM | -0.87 |
| EPS TTM | $-1.63 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 6.06 |
| EBITDA | $-65.67 M |
| Profit Margin | -49.91 |
MacroGenics, Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $13.19 M | $6.87 M | $72.84 M | $41.23 M | $20.77 M | $32.83 M |
| Gross Profit + | $7.79 M | $6.87 M | $61.25 M | $31.11 M | $11.24 M | $32.83 M |
| Operating Income | -$42.62 M | -$43.22 M | $18.64 M | -$12.10 M | -$33.44 M | -$13.85 M |
| EBITDA | -$40.85 M | -$41.32 M | $20.43 M | -$10.39 M | -$31.75 M | -$13.14 M |
| Interest Expense | -$91.00 K | -$802.00 K | -$3.34 M | -$4.27 M | -$4.89 M | -$4.40 M |
| Depreciation | $1.77 M | $1.91 M | $1.79 M | $1.71 M | $1.69 M | $708.00 K |
| Income Before Tax | -$41.04 M | -$42.61 M | $16.82 M | -$14.93 M | -$36.77 M | -$69.64 M |
| Income Tax Expense | $0 | $105.00 K | $0 | -$777.00 K | $0 | $0 |
| Net Income + | -$41.04 M | -$36.25 M | $16.82 M | -$14.15 M | -$36.77 M | $19.52 M |
| Net Profit Margin | -311.07% | -527.75% | 23.09% | -34.33% | -177.01% | 59.44% |
MacroGenics, Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $631.00 K | $632.00 K | $633.00 K | $633.00 K | $636.00 K | $637.00 K |
| Reserve & Surplus | -$1.21 B | -$1.25 B | -$1.23 B | -$1.24 B | -$1.28 B | -$1.26 B |
| Non-Current Liabilities | $90.00 M | $159.80 M | $159.29 M | $158.14 M | $100.73 M | $193.72 M |
| Current Liabilities | $55.44 M | $39.00 M | $44.47 M | $32.48 M | $95.94 M | $108.81 M |
| Total Liabilities | $145.45 M | $198.80 M | $203.76 M | $201.25 M | $196.68 M | $302.54 M |
| Fixed Assets | $16.88 M | $15.36 M | $13.97 M | $2.10 M | $11.49 M | $2.39 M |
| Current Assets | $182.09 M | $159.15 M | $232.09 M | $219.94 M | $182.52 M | $321.69 M |
| Total Assets | $224.56 M | $245.42 M | $270.76 M | $256.85 M | $217.87 M | $345.41 M |
MacroGenics, Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$41.04 M | -$36.25 M | $16.82 M | -$14.15 M | -$36.77 M | $19.52 M |
| Operating Cash Flow | -$46.89 M | -$46.98 M | -$30.19 M | $43.02 M | -$35.81 M | -$40.75 M |
| Investing Cash Flow | $9.90 M | -$37.64 M | -$20.37 M | -$65.99 M | $45.32 M | $27.96 M |
| Financing Cash Flow | -$282.00 K | $69.74 M | $0 | $57.00 K | -$207.00 K | $60.17 M |
| Change in Cash | -$37.27 M | -$14.88 M | -$50.56 M | -$22.91 M | $9.30 M | $47.39 M |
MacroGenics, Inc. Return Calculator
The MacroGenics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$2,002
Invested Amount$10,000
Est. Returns$-7,998
About MacroGenics, Inc.
Macrogenics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-based therapeutics for the treatment of cancer. The company is currently developing therapeutics utilizing multiple modalities, including antibody-drug conjugates (ADCs) and multi-specific antibodies (which it refers to as DART and TRIDENT molecules). It is advancing three proprietary product candidates in clinical development: lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload, and MGC028, an ADC that targets ADAM9 and delivers a novel TOP1i-based linker-payload. Its segment is developing and commercializing monoclonal antibody-based therapeutics.
Popular Stocks
FAQs
What is the share price of MacroGenics, Inc. today?
MacroGenics, Inc. (MGNX) share price as of September 18, 2026 is $4.10. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of MacroGenics, Inc.?
Yes, Indian Investors can invest in the MacroGenics, Inc. (MGNX) Share by opening an international trading account with Angel One.
How can I purchase MacroGenics, Inc. shares in India?
Purchasing MacroGenics, Inc. (MGNX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying MacroGenics, Inc. (MGNX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of MacroGenics, Inc.?
Yes, you can purchase fractional shares of MacroGenics, Inc. (MGNX) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of MacroGenics, Inc.?
The market capitalization of MacroGenics, Inc. on September 18, 2026, is $259.90 M.
In which sector MacroGenics, Inc. belongs?
MacroGenics, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in MacroGenics, Inc. stocks?
In order to invest in MacroGenics, Inc. (MGNX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
